Fibromyalgia
Conditions
Keywords
Fibromyalgia, Virtual Reality, Chronic Pain
Brief summary
Fibromyalgia is a frequent chronic pain syndrome almost often affecting women and associating diffuse chronic musculoskeletal pain (for more than 3 months), fatigue and sleep disturbances. Other varied functional symptoms are associated with it, in particular cognitive disorders and a feeling of unrested awakening. Technological advances in virtual reality have led to recognition by the medical community as a way to improve pain and quality of life for patients. There is a growing body of evidence supporting the use of virtual reality as an adjunct therapy to reduce acute pain in patients during medical procedures in hospital settings. There may also be a role for virtual reality in patients with chronic pain.
Detailed description
Current treatments for fibromyalgia (FM) include pharmaceutical pain medications as well as psychological programs with components of cognitive therapy, and activity management. However, pain medications are not fully effective, can be addictive, and can cause hyperalgesia. Non-pharmacological treatments for chronic pain may be associated with limiting side effects, technology-based interventions using virtual reality (VR) may be a promising alternative treatment option. There is evidence which shows that VR can be an effective treatment for pain reduction. However, most studies which utilize VR as a method of pain reduction focus on acute pain and studies looking at VR for chronic pain are scarce. Investigator will analyze the pain reduction and impact on behavioral mechanisms and cognition with repetitive active VR on Fibromyalgia
Interventions
None listed
Sponsors
Centre Hospitalier Princesse Grace
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
: * Patients able to understand and sign the informed consent form for the study * Adults aged 18 to 65 years * Followed in algology for fibromyalgia pain \> 6 months * With mean pain intensity ≥ 4
Exclusion criteria
: * History of epilepsy or hypersensitivity to flashing light to limit the risk of virtual reality-induced seizures * Previous use of VR for pain (possible bias) * Refusal to participate * Therapeutic modifications for pain management related to fibromyalgia during the first month of participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient pain | month 1 | Numerical Rating Scale, 0 to 10, 0 = no pain, 10 = maximal pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient pain | week 2, month 2 | Numerical Rating Scale, 0 to 10, 0 = no pain, 10 = maximal pain |
| Activity | month 1, month 2 | pain self-efficacy questionnaire, 0 to 60, 0 = not at all confident, 60 = completely confident |
| Mood | month 1, month 2 | Hospital Anxiety and Depression scale, 0 to 42, 7 or less = no symptom, 8 to 10 = doubt on symptom, 11 and more = undeniable symptom |
| Pain associated cognition | month 1, month 2 | Catastrophizing scale, 0 to 52, higher score indicates higher level of catastrophizing, a total score above 30 indicates clinically relevant level of catastrophizing |
Countries
Monaco
Outcome results
None listed